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ABSTRACT
Background: Radio frequency ablation (RFA) is one of the treatment modality for liver tumor either as primary 
tumor as well as secondary malignancy. Occasionally, a good ablation can’t be performed due to the tumor 
ORFDWLRQ7RDVVLVWVWKHDEODWLRQLQWKLVSDUWLFXODUFDVHVRPHÀXLGFDQEHGHSRVLWHGLQVLGHWKHDEGRPHQZKLFKLV
FDOOHGDVDUWL¿FLDODVFLWHV7KHDLPRIWKLVVWXG\LVWRUHSRUWDQGHYDOXDWHWKHPHWKRGRIDUWL¿FLDODVFLWHVLQ5)$
Method: This was a case series study consist of 19 consecutive patients that had been treated with ultrasound-
JXLGHG5)$XVLQJDUWL¿FLDODVFLWHVIURPWR
5HVXOWV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OHVLRQVLQ5)$¶VVHVVLRQVDQGWXPRUVL]HUDQJHVIURPPPWRPP0RVWRIWKHWXPRUV
were primary tumor (14/19). Nine patients had single tumor and 10 patients had multiple tumors and most of 
WKHWXPRUZHUHORFDWHGLQVHJPHQW$UWL¿FLDODVFLWHVZDVSHUIRUPHGXVLQJGH[WURVHLQZDWHU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Conclusion:3HUFXWDQHRXV5)$XVLQJDUWL¿FLDODVFLWHVWHFKQLTXHZDVVDIHDQGHIIHFWLYHIRUWUHDWLQJ+&&
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ABSTRAK 
Latar belakang: Radiofrequency ablation (RFA) merupakana salah satu modalitas terapi untuk tumor hati 
baik primer maupun sekunder. Pada beberapa kondisi, ablasi tidak dapat dilakukan akibat lokasi tumor. Untuk 
memfasilitasi ablasi pada kondisi seperti ini, ronga abdomen dapat diisi dengan cairan atau dikenal dengan 
DUWL¿FLDODVFLWHV7XMXDQGDULVWXGLLQLDGDODKPHQJHYDOXDVLPHWRGHDUWL¿FLDODVFLWHVSDGD5)$
Metode: Studi ini merupakan studi case series yang terdiri dari 19 pasien konsekutif yang telah diterapi 
GHQJDQ5)$WHUSLPSLQXOWUDVRQRJUD¿PHQJJXQDNDQDUWL¿FLDODVFLWHVGDULWDKXQKLQJJD
Hasil: $UWL¿FLDODVFLWHVVXNVHVGLODNXNDQSDGDVHOXUXKSDVLHQSDVLHQGHQJDQWRWDOOHVLNDUVLQRPD
VHOKDWL.6+SDGDVHVL5)$GDQXNXUDQWXPRUEHUNLVDUDQWDUDPPKLQJJDPP6HEDJLDQEHVDUWXPRU
adalah tumor primer (14/19). Tumor tunggal ditemukan pada 9 pasien dan 10 pasien memiliki tumor multipel. 
6HEDJLDQEHVDUWXPRUEHUDGDGLVHJPHQ7HNQLNDUWL¿FLDODVFLWHVGLODNXNDQPHQJJXQDNDQFDLUDQ
GH[WURVHLQZDWHU':GHQJDQYROXPHEHUNLVDUDQWDUDP/KLQJJDP/7LGDNGLWHPXNDQHIHNVDPSLQJ
baik pada sebelum maupun sesudah terapi.
Simpulan: 5)$SHUNXWDQGHQJDQDUWL¿FLDODVFLWHVPHUXSDNDQPRGDOLWDVWHUDSL.+6\DQJDPDQGDQHIHNWLI
Kata kunci: DUWL¿FLDODVFLWHVNDUVLQRPDKHSDWRVHOXODUUDGLRIUHTXHQF\DEODWLRQ
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INTRODUCTION
+HSDWRFHOOXODUFDUFLQRPD+&&LVWKHZRUOG¿IWKV
most common malignancy in male subjects. This 
malignancy is rank the 2nd most common cause of 
death related to malignancy in the world. In Indonesia, 
incidence of HCC is estimated will increased until 
2030 because of increasing number of patients with 
liver cirrhosis due to hepatitis B virus infection.1 One 
study revealed that only 34% patients with HCC that 
potentially cured and that because most patients came 
to the hospital with already advanced disease.2 Until 
now, curative treatment for HCC can be done with a 
very few modalities. 
Radio frequency ablation (RFA) is one of the 
curative methods for HCC. It is not clear whether RFA 
is as effective as liver resection which until now still 
considered as the treatment of choice for HCC.  There 
are two meta-analyses that showed hepatic resection 
is superior to RFA in small HCCs, particularly for 
tumors < 3 cm.3,4 But one meta-analysis showed no 
difference between hepatic resection and RFA in terms 
of overall survival rates.5 One randomized controlled 
trial revealed that percutaneous RFA is as effective 
as liver resection.6  Because RFA is a minimally 
invasive treatment, it can be used in patients who 
have an increased risk of complications for hepatic 
resection, including a decrease liver reserve of Child 
Pugh B status and suboptimal general condition with 
co-morbidities. However, several conditions may 
LQÀXHQFHWKHGHFLVLRQWRSHUIRUP5)$VXFKDVWXPRUV
abutting the diaphragm or near vital organs like the 
colon, bile duct, or gallbladder. These position not only 
FDXVHGLI¿FXOW\LQSHUIRUPLQJSHUFXWDQHRXVDEODWLRQ
but also increase the risk of thermal injury to adjacent 
organs. To perform RFA in this situation one may have 
WRFRQVLGHUDVVLVWDQWWHFKQLTXHWKDWLQFOXGHDUWL¿FLDO
DVFLWHVDUWL¿FLDOSOHXUDOHIIXVLRQRURWKHUPHDQVRI
procedure that can attenuate the heat damage by RFA. 
These assistant technique may protect the adjacent 
organ or give a clearer path for the RFA electrode to 
be put in desired positition to give a total ablation of 
the tumor. 
6RPHDUWL¿FLDODVFLWHVWHFKQLTXHRIIHUDUHODWLYHO\
H[SHQVLYHRUGLI¿FXOWWR¿QGDSSOLDQFHV7KHREMHFWLYH
of this article is to elucidate the feasibility and 
HIIHFWLYHQHVVRIDUWL¿FLDODVFLWHVLQGLI¿FXOWWRDEODWH
+&&VZLWK WKHPRGL¿FDWLRQ WHFKQLTXH WKDW VXLWDEOH
and cost effective for most clinical conditions because 
the use of apparatus that already in use in every day 
situation (such as spinal needle instead of special 
needle, and without any guide wire).  Therefore, the 
purpose of this study is to evaluate the method of 
DUWL¿FLDODVFLWHVXVLQJWHFKQLTXHWKDWZHGHYHORSHGWR
suit our condition and the availability of apparatus in 
our procedure room.
METHOD
This was a case series study consist of 19 patients 
WUHDWHGZLWK UDGLRIUHTXHQF\ DEODWLRQXVLQJ DUWL¿FLDO
ascites technique. The patients in this study required to 
SHUIRUPDUWL¿FLDODVFLWHVEHFDXVHRIGLI¿FXOWORFDWLRQ
to put the electrode or to avoid thermal injury to the 
adjacent organ. The inclusion criteria for the patients 
were: tumor accessible via a percutaneous approach, 
can be visualized using ultrasonography,  absence of 
portal/ hepatic vein main branch tumor thrombus; INR 
>1.6, platelet count > 50,000/ll, tumor size +/- 5.0 cm, 
and no tumor invasion of major surrounding structures. 
Baseline characteristic of the patients and reports of 
the procedure were recorded and summarized in result 
section of this study. We summarized all the patients 
data in Table 1.
$UWL¿FLDODVFLWHVZDVSHUIRUPHGE\LQWURGXFHVRPH
ÀXLG LQWR WKH SHULKHSDWLF SHULWRQHDO VSDFH SURYLGHV
a thermal barrier insulating the ablation zone from 
surrounding structures. Tumor visualization with 
XOWUDVRXQGLVRIWHQLPSURYHGDVWKHVXUURXQGLQJÀXLG
displaces the liver inferiorly and provides a sonographic 
ZLQGRZ$WRXULQVWLWXWLRQDUWL¿FLDODVFLWHVLVXWLOL]HG
if a patient is determined to have a tumor adjacent to 
critical structures, such as the diaphragm, stomach, 
bowel, or occasionally the lungs. D5W is typically 
XVHG IRU DUWL¿FLDO DVFLWHV LQ UDGLRIUHTXHQF\DEODWLRQ
as it is less ionic and presumed less likely to conduct 
electrical current.
We use 22G and 20G-spinal needle as local 
anesthetic needle as well as introduction needle for a 
VPDOOSRFNHWRIÀXLGDORQJWKHHGJHRIWKHOLYHU$VWKH
IRUPDWLRQRIWKHVPDOOSRFNHWRIÀXLGHVWDEOLVKHG*
or 16G iv-canulla needle can be safely inserted to allow 
the deposition of 500-1000 mL or more 5% dextrose. 
5% dextrose will be preferred because more non-ionic. 
Step by step method as follows: (1) Patient breath 
normally, no need to perform deep inspiration.  In this 
stage light sedation can be applied to the patient. A 
22G-Spinal needle (Spinocan) is placed just under the 
inferior edge of the liver tip with ultrasound guidance. 
Aspiration of the needle should not contained any 
aspirate nor gases; (2) 5-10 mL of 5% dextrose solution 
pushed to form a small pocket of hypoechoic area along 
the edge of the liver tip; (3) The needle can be changed 
to a 20G spinal needle (Spinocan) that by the help of 
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WKHVPDOOSRFNHWFDQLQWURGXFHPRUHÀXLGXQWLODERXW
100 mL. At this stage usually the area inferior the liver 
edge appeared hypoechoic; (4) A 16G or 14G iv canule 
put inside the hypoechoic area just under the infrior 
3LFWXUH3KDVHVRIFUHDWLQJDUWL¿FLDODVFLWHV
7DEOH6XPPDU\RIGDWDIURPFDVHVHULHV
Patient 
No Initial Sex Age (WLRORJ\ 1RGXOH+&&
Tumor 
Size
Lesion 
Amount
)UHT
RFA Segmen
1 BLS Male 64 NBNC Secondary 23 mm Multiple 3 V
V
V
2 S Female 70 HCV Primary 38 mm Single 1 VI
3 EP Male 57 HCV Primary 25 mm Single 1 VIII
4 A Male 59 HCV Primary 39 mm Multiple 9 V, VII
V, VII
V, VII, VIII
I, II, III
II, III
V, VI, VIII
II, IV
V, VI, VII
VIII
5 WSJ Male 63 HCV Primary 29 mm Single 1 IV
6 N Female 66 NBNC Secondary 25 mm Single 1 VII
7 SS Female 70 NBNC Primary 29 mm Single 1 IV
8 TSK Male 65 HBV Primary 14 mm Multiple 2 VII
IV
9 DS Female 67 HCV Primary 43 mm Multiple 1 VI, VIII
10 EW Female 65 HCV Primary 15 mm Single 1 VIII
11 SP Male 34 NBNC Secondary 20 mm Single 1 VIII
12 DD Male 65 NBNC Secondary 50 mm Multiple 2 V, VII
VI
13 HW Male 64 HBV Primary 37 mm Single 1 III
14 KL Male 53 HBV Primary 25 mm Multiple 1 V
15 LMD Male 64 HBV Primary 29 mm Multiple 1 VIII
16 IAN Female 56 NBNC Secondary NA Multiple 4 V, VI
V, VIII
IV
III, V
17 AK Male 46 HCV Primary NA Multiple 1 II, III
18 RA Female 25 HBV Primary 10 mm Multiple 1 II, III
19 PN Male 56 HBV Primary 15 mm Single 1 V
HGJHRIWKHOLYHU7KLVDOORZIRUPRUHUDSLGLQÀRZRI
5% dextrose into the abdominal cavity; (5) The amount 
RIÀXLGLQWURGXFHWRWKHDEGRPLQDOFDYLW\LVGHSHQGVRQ
the goal such as to separate the liver and the adjacent 
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organ or to bring out clearer visualization of the target 
nodule in the liver in order to give a good needle path. 
These objectives usually can be accomplished by 
500 – 1500 mL of solution; (6) The iv canule may be 
left indwelling during the procedure but care must be 
taken not to puncture or ablate the canule. At the end 
of the procedure the iv canule can be used to drain the 
ÀXLGLIQHFHVVDU\
7KLVVWXG\TXDOL¿HGXQGHUWKHFDWHJRU\RIH[HPSW
human subjects research, 45 CFR 46.101(b) (4): 
‘Research involving the collection or study of existing 
data, documents, records, pathological specimens, or 
diagnostic specimens, if these sources are publicly 
available or if the information is recorded by the 
investigator in such a manner that subjects cannot be 
LGHQWL¿HGGLUHFWO\RUWKURXJKLGHQWL¿HUVOLQNHGWRWKH
VXEMHFWV¶7KH FRQ¿GHQWLDOLW\ DQG DQRQ\PLW\ RI DOO
participating subjects was ensured at all times. Subject 
participation was completely voluntary and the patients 
did not come to any harm during the course of the 
study. The research was conducted in an independent 
and impartial manner.
RESULTS
$WRWDORIDUWL¿FLDODVFLWHVZHUHFRQGXFWHGLQ
patients treated with RFA. 12 (63.2%) patients were 
male and 7 were female (36.7%). The mean age of this 
patients was 64 years old with range of 29-70 years old. 
7 patients were infected with hepatitis C virus, 6 patiens 
were infected with hepatitis B virus, and 6 patiens were 
negative from hepatitis B and C virus infection (Table 2).
Liver function of the patiens were described. The 
mean of platelet counts (103/μL) was 188 with range 
of 53-974 and the mean of prothrombin time (%) was 
11.6 with range of 9.4-17.2. The mean of albumin (g/
dL) was 3.61 with range of 2.50-4.90 and the mean 
of total bilirubin (mg/dL) was 1.8 with range of 0.31-
2.70 (Table 2).
Most of the patients had cirrhosis (11/8) with the 
mean of Child Pugh (CP) Score was 5 with the range of 
5-8. 12 patients were CP(A) and 7 patients were CP(B). 
The mean of MELD score was 7 with the range of 6-16.
Nodule characteristic were also described. Most of 
the nodule were primary tumor (14/5) with mean size 
of 25mm. 9 patients had single nodule and 10 patients 
had multiple nodule. Total of 53 lesions had been 
treated in 34 RFA’s sessions. Most of the nodule were 
located in segment 5 (14/19) and only 1 nodule located 
in segment 1. All 53 nodules were successfully treated 
ZLWK5)$XVLQJDUWL¿FLDODVFLWHVZLWKQRUHWHQWLRQRI
ÀXLGDIWHUSURFHGXUH7DEOH
DISCUSSION 
RFA is accepted as one of effective method 
for treatment of liver tumor. This procedure were 
considered as effective as liver resection – the gold 
standard for treatment of liver cancer. Recent meta-
analysis showed that in studies where all tumors are 
considered resectable and patients are not grouped 
into the different treatment groups by baseline 
characteristics, liver resection is not shown to have 
VLJQL¿FDQWO\LPSURYHGDQG\HDURYHUDOOVXUYLYDO
and disease-free-survival when compared to RFA. 
Especially for tumor < 3 cm, no difference in terms 
7DEOH%DVHOLQHFKDUDFWHULVWLFVRIVWXG\SRSXODWLRQ
$UWL¿FLDODVFLWHVQ 
Sex (%)
   Male
   Female   
12 (63.2%)
7 (36.7%)
Age - range (years) 64 years (29-70 years)
Etiology (%)
   HBV Virus
   HCV Virus
   Non-B Non -C
6 (31.6%)
7 (36.8%)
6 (31.6%)
Platelet counts - range (103/ μL) 188 (53-974)
Prothrombin time - range (%) 11.6 (9.4-17.2)
Albumin - range (g/dL) 3.61 (2.50-4.90)
Bilirubin total - range (mg/dL) 1.18 (0.31-2.70)
Liver cirrhosis (%)
   Yes
   No
11 (57.9%)
8 (42.1%)
Child Pugh score (range) 5 (5-8)
Child Pugh (%)
   A
   B
12 (63.2%)
7 (36.8%)
Meld score (range) 7 (6-16)
Nodules HCC (%)
   Primary
   Secondary 
14 (73.7%)
5 (26.3%)
Lesion (%)
   Single 
   Multiple
9 (47.4%)
10 (52.6%)
7DEOH6XPPDU\RIUHVXOWVDUWL¿FLDODVFLWHVLQSDWLHQWVWUHDWHG
E\UDGLRIUHTXHQF\DEODWLRQ
Tumor size (range) 25 mm (10-50 mm)
$PRXQWRIIUHTXHQF\5)$ZLWKDUWL¿FLDO
ascites
34
Total number of Session 53
Segmen of RFA session (%)
   S1
   S2
   S3
   S4
   S5
   S6
   S7
   S8
1 (1.8%)
5 (9.4%)
6 (11.5%)
5 (9.4%)
14 (26.4%)
6 (11.5%)
7 (13.2%)
9 (16.8%)
Technical success rate (%)
   Success
   Unsuccess
53 (100%)
0 (0%)
Fluid intra-abdomen post RFA (%)
   Absence 
   Presence 
53 (100%)
0(0%)
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of overall survival between liver resection and RFA.7 
Moreover, patient with already compromised liver 
function, RFA still can be done. 
It is mandatory in patients with HCC, the tumor must 
be clearly visualized on US to avoid complications and 
to treat the tumor successfully.8  Percutaneous RFA 
has become widely used in HCC patients owing to 
LWV VDIHW\ DQG HI¿FDF\9,10,11 Recently, this modality 
for treatment of HCC is also included as one of the 
curative treatment in the expert consensus.12 However, 
5)$LVGLI¿FXOWWRSHUIRUPZKHQWKHWXPRULVORFDWHG
under the hepatic dome or near the surface of the liver, 
since visibility of the tumor on ultrasonography is 
not really clear, or abutting adjacent structures, such 
as the diaphragm, skin or organs that can be burned 
because of thermal injury during the process of RFA. 
These are several drawback of RFA that hampered the 
GHFLVLRQWRXVHWKLVPRGDOLW\$UWL¿FLDODVFLWHVFDQEH
XVHDQGRYHUFRPHPRVWFRQGLWLRQWRIXO¿OOWKHREMHFWLYH
RI5)$7KH WHFKQLTXHRI DUWL¿FLDO DVFLWHVZDV¿UVW
introduced in 1995. 
$UWL¿FLDO DVFLWHV WHFKQLTXH XVH LQ WKH IROORZLQJ
cases: (1) Failure to detect the tumor by usual 
ultrasonography because of tumor location, below 
the diaphragm, at the hepatic dome or left edge of 
the left lobe; (2) The proximity of the tumor to other 
vital organs, digestive tract, heart or diaphragm 
RFA is not easily performed because these are heat-
vulnerable organs, high risk for thermal damage (3) 
Lack of clarity in the ultrasonographic image of the 
whole tumor because of mesenteric interference or 
gasses in the intestine.13$QDUWL¿FLDODVFLWHV$$FDQ
effectively solved these problems.  The AA method is 
safe and practical when performing RF ablation for 
tumors adjacent to heat-vulnerable organs because it 
can separate the RF ablation zone from the adjacent 
organs and improve the visibility of an index tumor.14,15 
There were four different options of entry point 
for artificial ascites according to the location of 
hepatic tumor. Perihepatic route through the right 
7-8 intercostal space or a sub-hepatic route below 
the hepatic angle along the anterior axilary line is 
recommended for tumor located in right lobe and 
segment 4. Another entry point is sub-xiphoid for 
tumor located in segments 2,3, and 4 abutting the 
diaphragmgm.16 
Several techniques have been described to 
percutaneously separate the ablation site from adjacent 
structures. Fluid can be put into the pleural space to 
FUHDWHDUWL¿FLDOSOHXUDOHIIXVLRQ LQRUGHU WR LPSURYH
visualization of peridiaphragmatic hepatic tumors.17,18 
This method have risk of respiratory compromise 
which may be already co-morbidity with liver cancer. 
)XUWKHUPRUH YROXPH RI ÀXLG LQMHFWHG DUH OLPLWHG
and unable to separate the diaphragm from the liver. 
Angiographic balloon catheters have been tried and can 
be deployed between the liver and adjacent tissue, with 
expansion of the catheter providing space and buffering 
from the ablation zone.19,20,21 The use of the balloon can 
be advantageous as they are not gravity dependent but 
this method is cumbersome and need more resources 
EHFDXVH WKH\ FDQEHGLI¿FXOW WR SRVLWLRQ HVSHFLDOO\
in tumors located far from the body surface, may 
rupture because of thermal damage, or interfere with 
XOWUDVRXQG LPDJLQJ 6RPHWLPHVPDQXDO GHÀHFWLRQ
of the ablation zone by applying torque or pushing/
pulling on the ablation applicator may occasionally 
be successful in displacing the tumor ablation zone 
from adjacent structures.19,22 However, this technique 
PD\EHGLI¿FXOWLQGHHSOHVLRQVRUPD\IDLOWRFUHDWH
an adequate gap between the liver and perihepatic 
structures. There is also potential risk of tissue injury 
IURPH[FHVVLYHDSSOLFDWRUGHÀHFWLRQ
$UWL¿FLDODVFLWHVFDQEHXVHWRVHSDUDWHWKHDGMDFHQW
structure in order to avoid thermal injury and give a 
clear electrode path to the tumor percutaneously.23 
Kang et al, study the role of AA in RFA of a single 
HCC abutting the diaphragm. They divided 44 patients 
LQWRWZRJURXSVWKHDUWL¿FLDODVFLWHVJURXSDQGFRQWURO
group. They found that right shoulder pain and transient 
OXQJ LQMXU\ZHUHVLJQL¿FDQWO\PRUHSUHYDOHQW LQ WKH
FRQWURO JURXS WKDQ LQ WKH DUWL¿FLDO DVFLWHV JURXS
LQGLFDWLQJWKHSURWHFWLYHHIIHFWRIDUWL¿FLDODVFLWHVLQ
RFA for HCCs abutting the diaphragm.24
Several method of performing AA have been done. 
.RQGRHWDOXVH*QHHGOHZLWKDPHWDOOLFÀDWFXW
trocar and a diamond-cut inner stylet that was designed 
IRU LQIXVLRQ RI DUWL¿FLDO DVFLWHV XQGHU UHDOWLPH
ultrasonographic guidance as initial puncture needle, 
followed by infusion of 5% dextrose into perihepatic 
space just under the inferior border of the liver.25
We modified their technique because metallic 
QHHGOHZLWKÀDWFXWWURFDUGDQGLDPRQGFXWV\OHWLVQRW
availabe. In this series, we use 22G spinal needle to 
PDNHDSRFNHWRIÀXLGMXVWEHORZWKHLQIHULRUERUGHU
RI WKH OLYHU$IWHU WKH SRFNHW RI ÀXLGZDV IRUPHG
slightly bigger 20G-spinal needle inserted to ease the 
DGPLQLVWUDWLRQ RIPRUHÀXLG DQG WKHQ *RU *
,9FDQXOHQHHGOHZHUHSXW LQVLGH WKHÀXLG OLQH WKDW
formed. Liu et al use 18G-PTC needle as introducer 
needle before they put verress needle to administered 
WKHÀXLGLQWRSHULWRQHDOFDYLW\26 As introducer needle 
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we consider these needle were big and may potentially 
have bigger risk of perforate or damage to adjacent 
organ. Chen MH et al injected 30-200 mL aseptic 
solution between the tumor and diaphragm which 
may be not enough to form a good separation. They 
reported 3.2% of major complication during  RFA.27 
Uehara et al insert a 21-gauge needle just in front of 
the surface of the liver to inject 5% glucose which is 
QRWFOHDUZKHWKHUWKHÀXLG¿OOLQWKHSHULWRQHDOFDYLW\
or only restricted at the liver capsule.28
Nishimura et al use the needle like ours but they 
penetrated the liver surface which we consider have a 
higher risk of bleeding. Moreover, their method need 
patients full cooperation in order to regulate inspiration 
because they need maximum inspiration while they 
inserted the needle, such action that we cannot done 
because our patient were already sedated from the 
beginning of the procedure to give the patients some 
comfort.29 Asvadi et al use 19G-coaxial needle that 
inserted with CT guidance to the anterior surface of 
the liver that we consider high risk to peneterate the 
liver.30 Others use angiosheath and guide wire which 
are relatively more expensive.31,32,33  
,QPDMRULW\DUWL¿FLDODVFLWHVFDQEHGRQHVXFFHVVIXOO\
without any complication. In our series, 100% of cases 
DUWL¿FLDO DVFLWHVFDQEHDFFRPSOLVKHGDQG IXO¿OO WKH
objectives whether it was to separate the adjacent 
structure to avoid thermal damage, clear the path of 
electrode or bring up the nodule so it can be visualize 
E\XOWUDVRQRJUDSK\5KLPHWDOVKRZHGWKDWDUWL¿FLDO
ascites was successfully achieved in 22 (88%) of 
25 patients. They reported marked improvement in 
the visibility in 93.4% (15/16) of the tumor and a 
better path for electrode in 77.8% (7/9). The primary 
technique effectiveness rate for hepatic dome tumors 
was 96% (24/25) and no diaphragmatic thermal injury 
in all but one case.32 Nishimura et al also found high 
VXFFHVVUDWHRISHUIRUPLQJDUWL¿FLDODVFLWHV,Q
WKHLUVHULHVQRVLJQL¿FDQWGLIIHUHQFHVZHUHREVHUYHG
with respect to age, tumor size, or number of treatment 
sessions.29 Liu et al reported technical success rate 
IRULQGXFWLRQRIDUWL¿FLDODVFLWHVZHUH
7KHSURFHGXUHVKDGDFKLHYHGSUHGH¿QHGJRDOVLQ
(92.9%) patients. Others also reported the same high 
VXFFHVVUDWHRISHUIRUPLQJDUWL¿FLDODVFLWHV13,15
:KHWKHUDEGRPLQDOVXUJHU\KDYHDQ\LQÀXHQFHRQ
VXFFHVVUDWHRILQGXFWLRQRIDUWL¿FLDODVFLWHVUHPDLQ
controversial. Kang et al reported that hepatic resection 
can severely impaired success rate of performing 
DUWL¿FLDO DVFLWHV IURP WR15  However, 
Kondo et al found no difference in the success of 
performing artificial ascites between patient with 
history of abdominal surgery or not.25
$UWL¿FLDODVFLWHVFDQJLYHVSDFHEHWZHHQWKHOLYHU
VXUIDFH DQG DGMDFHQW RUJDQV7KHÀXLG EHWZHHQ WKH
liver and the gastrointestinal tract plays a role in 
insulating thermal energy transmission and lowering 
the temperature around the liver, thus protecting the 
adjacent structure from thermal injury. Although 
artificial ascites insulate adjacent structure from 
WKHUPDOLQMXU\EXW.LPHWDOIRXQGWKDWDUWL¿FLDODVFLWHV
did not cause a heat-sink effect, which can affect the 
HI¿FDF\RI5)DEODWLRQ31 Kang et al study to compare 
EHWZHHQSDWLHQWZLWKDUWL¿FLDODVFLWHVDQGFRQWUROJURXS
and they found that the mean diaphragmatic thickness 
on CT scans immediately after RF ablation was 1.88 
PP LQ WKH DUWL¿FLDO DVFLWHV JURXS DQG PP LQ
the control group diaphragmatic thickness increase 
from the condition before radiofrequency ablation to 
WKDWLPPHGLDWHO\DIWHUZDVPPIRUWKHDUWL¿FLDO
ascites group and 1.55 mm for the control group; 
WKHVH GLIIHUHQFHVZHUH VWDWLVWLFDOO\ VLJQL¿FDQW S 
0.01). Follow-up CT scans showed that swelling of the 
diaphragm in both groups decreased with time. Seven 
SDWLHQWVLQWKHFRQWUROJURXS EXWRQO\
RQHSDWLHQW LQWKHDUWL¿FLDODVFLWHVJURXS
had right shoulder pain after radiofrequency ablation.24 
+DNLPHHWDOUHSRUWHGWKDWDUWL¿FLDODVFLWHVVLJQL¿FDQWO\
decreases post-operative pain for peripheral large 
ablation by avoiding peritoneal burning.34 
$OWKRXJKDUWL¿FLDODVFLWHVLVEHQH¿FLDOWRUHGXFHWKH
KHDWLQMXU\WRWKHDGMDFHQWVWUXFWXUHDUWL¿FLDODVFLWHV
does not have any heat-sink effect. Nam et al evaluate 
RQHJURXSZLWKDUWL¿FLDODVFLWHVDQGWKHRWKHUJURXS
as control. They found that mean volume of the RFA 
]RQHZDVFPLQJURXSDUWL¿FLDODVFLWHV
SDWLHQWVDQGFPLQFRQWUROJURXSS 
7KHLU FRQFOXVLRQZHUH WKDW DUWL¿FLDO DVFLWHV
does not have heat-sink effect and therefore it does 
QRWLQÀXHQFHWKHHI¿FDF\RIDEODWLRQ35 
$UWL¿FLDODVFLWHVLPSURYHVWXPRUYLVLELOLW\EHFDXVH
LWSXVKHGWKHLQWHVWLQHWKDWLVXVXDOO\¿OOHGZLWKDLUDQG
FKDQJHLWZLWKÀXLGWKDWLVPRUHEHQH¿FLDOLQWHUPVRI
conductivity of ultrasound. This is really true in case 
of small tumor at the dome of the liver.  In a previous 
study of 25 patients with HCCs in the hepatic dome, 
substantial improvement in visibility was achieved in 
93.4 % (15/16) of the patients, and a more favorable 
electrode path was obtained in 77.8 % (7/9) of the 
patients.14 
+&&V DW GLI¿FXOW ORFDWLRQV DUH WHFKQLFDOO\PRUH
demanding to ablate than centrally located HCCs even 
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DIWHUWKHLQIXVLRQRIDUWL¿FLDODVFLWHV7KHUHIRUHPRUH
sessions of RFA are required to achieve the complete 
DEODWLRQRI+&&VDWGLI¿FXOWORFDWLRQV+RZHYHUWKH
complete ablation and local tumor progression rates 
DUHFRPSDUDEOH,QEULHI5)$ZLWKDUWL¿FLDODVFLWHVLV
DQHIIHFWLYH WKHUDS\IRU+&&VDWGLI¿FXOW ORFDWLRQV
However, a conclusion has not been reached because 
of limited studies with few case.23 
$UWL¿FLDODVFLWHVSURFHGXUHPD\OHDGWRFRPSOLFDWLRQV
such as intraperitoneal bleeding or intestinal perforation, 
however no major complications have been reported 
in the literature. In their study, Jeong YS et al found 
no severe complications such as peritoneal bleeding, 
intestinal perforation, liver abscess, liver infarction, 
pneumothorax, biliary tract injury, skin burns, lung 
burns, uncontrolled ascites, or uncontrolled pleural 
effusion were observed. The stomach is the most 
frequent injured organ (28/ 52, 53.8%), followed by 
colon (17/52, 32.7%) and small bowel (7/52, 13.5%). 
Patients with complication tend to had thicker bowel 
wall than those with minor complication (1.8 ± 0.1 vs. 
FPS 167KH\IRXQGWKDWJDVWURLQWHVWLQDO
tract (GIT) injury after hepatic RFA is rare (1.32%, 
52/3933) and that major GIT complication requiring 
bowel surgery is extremely uncommon (0.05%, 2/3933). 
This result follows previous literature that reports the 
complication incidences of 0.1–0.3%. All of these 
complications may be related to RFA procedure rather 
WKDQWKHDUW¿FLDODVFLWHV36  
Complication of peritoneal cavity bleeding also 
analyzed in several studies. Hakime et al, found that 
DUWL¿FLDODVFLWHVGLGQRWLQFUHDVHWKHUDWHRIEOHHGLQJ
6HYHUDOVWXG\DOVRUHSRUWHGWKDWDUWL¿FLDODVFLWHVGRHV
not have major complication.13,25,29,34 
Long-term local tumour control and risk of 
peritoneal seeding were comparable for RFA with 
RUZLWKRXWDUWL¿FLDODVFLWHVZKHQXVHGDVD¿UVWOLQH
therapy for subcapsular HCC. A recent study showed 
that the rate of peritoneal seeding was 6.8 % (3/44) in 
DQDUWL¿FLDODVFLWHVJURXSDQGLQDFRQWURO
JURXS1RVLJQL¿FDQWGLIIHUHQFHZDVQRWHGEHWZHHQ
WKHVHWZRJURXSVVXJJHVWLQJWKDW5)$ZLWKDUWL¿FLDO
ascites for the ablation of subcapsular HCCs did not 
increase the risk of peritoneal seeding.24
CONCLUSION 
In this study we conclude that ultrasound-guided 
SHUFXWDQHRXV5)$XVLQJDUWL¿FLDODVFLWHVWHFKQLTXHZDV
safe and effective for treating primary and secondary 
KHSDWLFWXPRXUV$UWL¿FLDODVFLWHVRIIHUJRRGVHSDUDWLRQ
from other vital organ to further enhance the safety of 
WKHSURFHGXUH:HGLGQRW¿QGDQ\VHULRXVFRPSOLFDWLRQ
to this thecnique, however the authors believe that more 
studies required to be perform in order to convince the 
VDIHW\DQGHI¿FDF\RIWKLVWHFKQLTXH
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